OPX Biotechnologies' Series C Round

OPX Biotechnologies raised a round of funding on July 15, 2011.

The OPX EDGE (Efficiency Directed Genome Engineering) technology platform enables rapid, rational, and robust optimization of microbes and bioprocesses to manufacture bioproducts with equivalent perfo…

Articles about OPX Biotechnologies' Series C Round: